When Sprays Stop Working: Surgery for Non-Allergic Rhinitis

Non-allergic rhinitis (NAR) is a frequent and underdiagnosed cause of persistent nasal symptoms, including congestion, rhinorrhoea, and nasal hyperreactivity. Its pathophysiology is heterogeneous, but neurogenic dysregulation — with excessive mucus production and vasodilation — is a central mechanism.

Medical therapy remains first-line. Surgical intervention is indicated when symptoms persist despite adequate medical treatment, correct technique, and adherence. The selection of procedure should be guided by the predominant symptom profile, nasal anatomy, and prior treatment response.

Inferior Turbinate Reduction for Nasal Obstruction

Inferior turbinate hypertrophy is the principal surgical target in obstruction-predominant NAR. Available techniques include cold-instrument reduction, laser, radiofrequency turbinoplasty, coblation-assisted turbinoplasty, and microdebrider-assisted turbinoplasty.

Inferior turbinate reduction remains the cornerstone treatment for obstruction, providing durable symptom relief with low complication rates. Mucosa-sparing approaches are generally preferred to preserve nasal function and minimize the risk of crusting, synechiae, and empty nose syndrome.

Turbinate reduction has no established effect on sneezing, nasal itching, or postnasal drip. An additional benefit on rhinorrhoea has been reported for microdebrider-assisted turbinoplasty.

Vidian Neurectomy for Severe, Refractory Rhinorrhoea

Vidian neurectomy interrupts parasympathetic supply to the nasal mucosa and effectively reduces rhinorrhoea. However, because the vidian nerve also contributes to lacrimal innervation, the procedure carries risks of ocular dryness and transient facial numbness.

Accordingly, its indication is limited to severe, refractory cases in which less invasive measures have failed.


Posterior Nasal Nerve Ablation (PNN)

Posterior nasal nerve (PNN) ablation provides a minimally invasive, outpatient alternative. Cryotherapy, cold-instrument techniques, and radiofrequency ablation selectively target nasal parasympathetic and sensory fibres while sparing lacrimal innervation.

PNN intervention yields significant and lasting symptom improvement and is therefore an appropriate first-line nerve-targeting option for many patients with rhinorrhoea-predominant NAR.


Conclusion

Surgical management of NAR is effective and safe when tailored to symptom profile, anatomy, and prior medical treatment response. Advances in endoscopic and minimally invasive techniques have reduced complications and established these procedures as integral components of comprehensive NAR care.

This article is for educational purposes and does not constitute medical advice.

References

Lundberg M, van Waterschoot J, Moyaert M, et al. Surgical Management of Non-Allergic Rhinitis — An EAACI Task Force Position Paper. Allergy. 2026;81(11):3779-3796. doi:10.1111/all.70424.

Hellings PW, Klimek L, Cingi C, et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017;72(11):1657-1665. doi:10.1111/all.13200.